Advertisement

Topics

Nippon Chemiphar Announces Progress on Its Hyperuricemia/Gout Projects; NC-2500 Shows Favorable ...

00:00 EST 29 Nov 2017 | BioMedReports - Blog

NC-2500 showed favorable urate-lowering properties which may make a difference in gout treatment. NC-2500 lowered serum urate levels gradually to the same extent as current

Read more...

Original Article: Nippon Chemiphar Announces Progress on Its Hyperuricemia/Gout Projects; NC-2500 Shows Favorable ...

NEXT ARTICLE

More From BioPortfolio on "Nippon Chemiphar Announces Progress on Its Hyperuricemia/Gout Projects; NC-2500 Shows Favorable ..."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Gout
According to the National Arthritis Data Workgroup, an estimated 6 million people in the United States report having experienced gout at some point in their lives. In fact, gout is the most common form of inflammatory arthritis in men over the age of 40....